Inmode Ltd (INMD)

Apr 3, 2025, 4:26 AM EDT - 17 days ago

InMode: Strategic Capital Allocation Unlocks Shareholder Value (Rating Upgrade)

Mar 26, 2025, 8:30 AM EDT - 24 days ago

InMode to Present at the 24th Annual Needham Virtual Healthcare Conference

Mar 6, 2025, 7:30 AM EST - 6 weeks ago

InMode Responds to Doma Perpetual's Letters

Mar 3, 2025, 8:30 AM EST - 6 weeks ago

InMode to Present at Upcoming Investor Conferences

Feb 10, 2025, 1:14 AM EST - 2 months ago

InMode: Plastic Surgery Boom, Cash Flow, And Cheap

Feb 6, 2025, 9:08 AM EST - 2 months ago

InMode Ltd. (INMD) Q4 2024 Earnings Call Transcript

Feb 4, 2025, 7:00 AM EST - 2 months ago

InMode Reports Fourth Quarter and Full Year 2024 Financial Results; Board of Directors Has Approved a New Share Repurchase Program

Feb 3, 2025, 8:30 AM EST - 2 months ago

InMode to Participate in the BTIG MedTech, Digital Health, Life Sciences & Diagnostics Tools Conference

Jan 28, 2025, 9:32 AM EST - 2 months ago

InMode: A Clear Bargain With Unique Risks

Jan 16, 2025, 7:00 AM EST - 3 months ago

InMode to Report Fourth Quarter & Full Year 2024 and Hold Conference Call on February 4, 2025, Earlier than Originally Announced

Jan 15, 2025, 8:05 AM EST - 3 months ago

DOMA Perpetual Sends Letter Urging Board of Directors of InMode Ltd. to Immediately Execute Tender Offer followed by Share Buyback

Jan 10, 2025, 6:07 AM EST - 3 months ago

InMode: Clearly, I Was Too Optimistic (Rating Downgrade)

Jan 8, 2025, 7:00 AM EST - 3 months ago

InMode to Report Fourth Quarter & Full Year 2024 Financial Results and Hold Conference Call on February 6, 2025, Expects Q4 Revenue Between $97.0M-$97.5M

Dec 12, 2024, 1:17 AM EST - 4 months ago

InMode: Product Origination And Undervaluation Make The Stock A Buy

Nov 5, 2024, 9:43 AM EST - 5 months ago

InMode: $25/Share Is Closer Than You Think

Oct 31, 2024, 12:16 PM EDT - 6 months ago

InMode: A Deep Dive After Q3 Earnings

Oct 30, 2024, 11:33 AM EDT - 6 months ago

InMode Ltd. (INMD) Q3 2024 Earnings Call Transcript

Oct 30, 2024, 7:00 AM EDT - 6 months ago

InMode Reports Third Quarter 2024 Financial Results; Quarterly GAAP Revenue of $130.2 Million (which consists of $98.3 million of net sales in Q3 and $31.9 million of pre-orders from the first half of 2024)

Oct 24, 2024, 7:03 AM EDT - 6 months ago

InMode Granted Preliminary Injunction Against Online Sellers Prohibiting Counterfeit Sales of Morpheus8 Radiofrequency Devices and Cartridge Accessories

Oct 10, 2024, 7:00 AM EDT - 6 months ago

InMode to Report Third Quarter 2024 Financial Results and Hold Conference Call on October 30, 2024

Oct 4, 2024, 8:00 AM EDT - 7 months ago

Stock Picks From Seeking Alpha's September 2024 New Analysts

AME CCL CRWD CUK DVN EGO EMR

Oct 1, 2024, 7:00 AM EDT - 7 months ago

InMode Announces Departures of President of North America, Chief Medical Officer and VP of Sales USA as Part of a Global Reorganization Strategy

Sep 19, 2024, 7:14 AM EDT - 7 months ago

InMode Offers High Risk-Reward Opportunity Amid New Products And Rate Cuts (Rating Upgrade)

Sep 10, 2024, 7:00 AM EDT - 7 months ago

InMode Announces Share Repurchase Program of Up to 7.68 Million Shares

Sep 6, 2024, 4:38 AM EDT - 8 months ago

InMode Stock: An Inverse Bubble Caused By Short-Term Trouble

Sep 4, 2024, 8:30 AM EDT - 8 months ago

InMode to Present at 2024 Baird Global Healthcare Conference

Aug 1, 2024, 11:19 AM EDT - 9 months ago

InMode Ltd. (INMD) Q2 2024 Earnings Call Transcript

Aug 1, 2024, 7:00 AM EDT - 9 months ago

InMode Reports Second Quarter 2024 Financial Results; Quarterly Revenue of $86.4M Represents 36.5% Year-Over-Year Decrease; Pro Forma Revenue (including new platform pre-orders not yet delivered) of $102.6M

Jul 31, 2024, 8:03 AM EDT - 9 months ago

InMode Introduces IgniteRF The Complete Minimally Invasive Soft Tissue Contraction Platform

Jul 25, 2024, 8:15 AM EDT - 9 months ago

DOMA Perpetual Sends Letter to the Board of Directors of InMode Urging the Execution of a 40% Tender Offer

Jul 17, 2024, 8:03 AM EDT - 9 months ago

Morpheus8 Secures First and Only FDA Clearance for Soft Tissue Contraction for Fractional Radiofrequency Microneedling

Jul 11, 2024, 8:30 AM EDT - 10 months ago

InMode to Report Second Quarter 2024 Financial Results and Hold Conference Call on Aug. 1, 2024

Jun 13, 2024, 11:49 AM EDT - 11 months ago

InMode: Reversing Previous Shareholder Dilution With Buybacks

May 16, 2024, 8:00 AM EDT - 1 year ago

InMode to Present at Jefferies Healthcare Conference

May 8, 2024, 8:03 AM EDT - 1 year ago

InMode Announces P1 Offshore Racing Partnership with Female Driver Victoria Rand

May 2, 2024, 7:00 AM EDT - 1 year ago

InMode Reports First Quarter 2024 Financial Results; Quarterly Revenue of $80.3M Represents 24% Year-Over-Year Decrease; Pro Forma Revenue (including new platform pre-orders not yet available) of $96M;

Apr 15, 2024, 9:00 AM EDT - 1 year ago

IMPORTANT DEADLINE TODAY: The Schall Law Firm Encourages Investors in InMode Ltd. with Losses of $500,000 to Contact the Firm

Apr 15, 2024, 7:00 AM EDT - 1 year ago

InMode Responds To BTL Petition for Inter Partes Review Of Patent InMode Is Asserting Against BTL

Apr 15, 2024, 3:30 AM EDT - 1 year ago

FINAL DEADLINE TODAY: The Schall Law Firm Encourages Investors in InMode Ltd. with Losses of $500,000 to Contact the Firm

Apr 14, 2024, 6:45 PM EDT - 1 year ago

SHAREHOLDER DEADLINE TOMORROW: The Schall Law Firm Encourages Investors in InMode Ltd. with Losses of $500,000 to Contact the Firm

Apr 13, 2024, 8:00 PM EDT - 1 year ago

FINAL DEADLINE MONDAY: The Schall Law Firm Encourages Investors in InMode Ltd. with Losses of $500,000 to Contact the Firm

Apr 13, 2024, 9:00 AM EDT - 1 year ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of InMode

Apr 10, 2024, 7:00 AM EDT - 1 year ago

FINAL DEADLINE IMMINENT: The Schall Law Firm Encourages Investors in InMode Ltd. with Losses of $500,000 to Contact the Firm

Apr 9, 2024, 7:00 AM EDT - 1 year ago

InMode to Report First Quarter 2024 Financial Results and Hold Conference Call May 2, 2024